An economic review of the national screening policy to prevent thalassemia major in Iran
This Paper is to describe the economic burden of thalassemia as a major health problem in thalassemia belt countries like Iran. Great emphasis is placed on prenatal diagnosis to prevent the disease, as the "economic" solution from a health care policy viewpoint. The alternative method of the current screening program in Iran is outlined and discussed especially with respect to the "cost-effectiveness" issue, along with some pitfalls of the general plan and the techniques under use. Further follow-up of program after such refinement is advised, and especially the provision of a working option of prenatal diagnosis to carrier couples is recommended.
To our knowledge, this item is not available for
download. To find whether it is available, there are three
1. Check below under "Related research" whether another version of this item is available online.
2. Check on the provider's web page whether it is in fact available.
3. Perform a search for a similarly titled item that would be available.
|Date of creation:||Dec 2002|
|Date of revision:|
|Contact details of provider:|| Postal: Yoshida-Honmachi, Sakyo-ku, Kyoto 606-8501|
Web page: http://www.kier.kyoto-u.ac.jp/eng/index.html
More information through EDIRC
When requesting a correction, please mention this item's handle: RePEc:kyo:wpaper:562. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Ryo Okui)
If references are entirely missing, you can add them using this form.